Human intraocular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration

Authors

Seenu M. Hariprasad, Washington University School of Medicine in St. Louis
William F. Mieler, University of Chicago
Gaurav K. Shah, Washington University School of Medicine in St. Louis
Kevin J. Blinder, Washington University School of Medicine in St. Louis
Rajendra S. Apte, Washington University School of Medicine in St. Louis
Nancy M. Holekamp, Washington University School of Medicine in St. Louis
Matthew A. Thomas, Washington University School of Medicine in St. Louis
Jingduan Chi, University of Houston
Randall A. Prince, University of Houston

Journal

Transactions of the American Ophthalmological Society

Publication Date

2004

Volume

102

Inclusive Pages

149-157

Document Type

Open Access Publication

Rights and Permissions

Hariprasad SM, Mieler WF, Shah GK, Blinder KJ, Apte RS, Holekamp NM, Thomas MA, Chi J, Prince RA. 2004. Human intraocular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration. Transactions of the American Ophthalmological Society; 102: 149-157.

Recommended Citation

Hariprasad, Seenu M.; Mieler, William F.; Shah, Gaurav K.; Blinder, Kevin J.; Apte, Rajendra S.; Holekamp, Nancy M.; Thomas, Matthew A.; Chi, Jingduan; and Prince, Randall A., "Human intraocular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration." Transactions of the American Ophthalmological Society. 102, 149-157. (2004).
https://digitalcommons.wustl.edu/open_access_pubs/3309